Response of Endometrial Endometrioid Adenocarcinoma With and Without Mismatch Repair Deficiency to Exogenous Progestin Therapy

被引：0
|
作者：
Cook, Eleanor [1 ]
Shetty, Sindhu [2 ]
Tewari, Surabhi [2 ]
Joehlin-Price, Amy [2 ]
机构：
[1] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
MODERN PATHOLOGY | 2021年 / 34卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
556
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [31] Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma
    Gan, Qiong
    Crumley, Suzanne
    Broaddus, Russell R.
    LABORATORY INVESTIGATION, 2017, 97 : 286A - 286A
  • [32] Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma
    Gan, Qiong
    Crumley, Suzanne
    Broaddus, Russell R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (01) : 44 - 51
  • [33] Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma
    Gan, Qiong
    Cruinley, Suzanne
    Broaddus, Russell R.
    MODERN PATHOLOGY, 2017, 30 : 286A - 286A
  • [34] Mismatch repair status in high-grade endometrial carcinomas of endometrioid and non-endometrioid type
    Doulgeraki, Triada
    Vagios, Stylianos
    Kavoura, Evangelia
    Yiannou, Petros
    Messini, Irini
    Nonni, Afroditi
    Papadimitriou, Christos
    Vlachos, Athanassios
    Pavlakis, Kitty
    JOURNAL OF BUON, 2019, 24 (05): : 2020 - 2027
  • [35] Clinicopathologic features of endometrial cancer with mismatch repair deficiency
    Gordhandas, Sushmita
    Kahn, Ryan M.
    Gamble, Charlotte
    Talukdar, Nizam
    Maddy, Brandon
    Nelson, Becky Baltich
    Askin, Gulce
    Christos, Paul J.
    Holcomb, Kevin
    Caputo, Thomas A.
    Chapman-Davis, Eloise
    Frey, Melissa K.
    ECANCERMEDICALSCIENCE, 2020, 14
  • [36] Identifying biomarkers of response to progestin therapy in conservatively managed endometrial cancer and atypical hyperplasia/endometrioid intraepithelial neoplasia
    Acosta-Torres, Stefany
    Murdock, Tricia
    Beavis, Anna
    Gough, Ethan
    Fader, Amanda Nickles
    Shih, Ie-Ming
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S142 - S142
  • [37] Prognostic role of mismatch repair protein defect in endometrioid type of endometrial carcinoma
    El Anwar, N.
    Eid, A.
    Ezzeldin, S.
    VIRCHOWS ARCHIV, 2020, 477 : S62 - S62
  • [38] Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens
    Chapel, David B.
    Yamada, S. Diane
    Cowan, Matthew
    Lastra, Ricardo R.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 570 - 574
  • [39] Prognostic Impact of Mismatch Repair Deficiency on Stage I-II Endometrioid Endometrial Cancer Treated with Adjuvant Radiation Therapy: A Multi -Institutional Analysis
    Sherwani, Z.
    Alegun, J.
    Russo, A. L.
    Damast, S.
    Albuquerque, K. V.
    Nwachukwu, C. R.
    Dyer, M. A.
    Fields, E. C.
    Beriwal, S.
    Horne, Z. D.
    Vergalasova, I.
    Ohri, N.
    Taunk, N. K.
    Chino, J. P.
    Kidd, E. A.
    Leung, E. W.
    Song, J.
    Hathout, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S8 - S8
  • [40] Clinicopathological Implications of Mismatch Repair Status in Endometrioid Endometrial Cancer in Duhok City
    Ali, Ghorbat S.
    Yaqo, Rafil T.
    Abdullah, Mahdi A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
12345